Thioredoxin Is Involved in Endothelial Cell Extracellular Transglutaminase 2 Activation Mediated by Celiac Disease Patient IgA

7Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Purpose:To investigate the role of thioredoxin (TRX), a novel regulator of extracellular transglutaminase 2 (TG2), in celiac patients IgA (CD IgA) mediated TG2 enzymatic activation.Methods:TG2 enzymatic activity was evaluated in endothelial cells (HUVECs) under different experimental conditions by ELISA and Western blotting. Extracellular TG2 expression was studied by ELISA and immunofluorescence. TRX was analysed by Western blotting and ELISA. Serum immunoglobulins class A from healthy subjects (H IgA) were used as controls. Extracellular TG2 enzymatic activity was inhibited by R281. PX12, a TRX inhibitor, was also employed in the present study.Results:We have found that in HUVECs CD IgA is able to induce the activation of extracellular TG2 in a dose-dependent manner. Particularly, we noted that the extracellular modulation of TG2 activity mediated by CD IgA occurred only under reducing conditions, also needed to maintain antibody binding. Furthermore, CD IgA-treated HUVECs were characterized by a slightly augmented TG2 surface expression which was independent from extracellular TG2 activation. We also observed that HUVECs cultured in the presence of CD IgA evinced decreased TRX surface expression, coupled with increased secretion of the protein into the culture medium. Intriguingly, inhibition of TRX after CD IgA treatment was able to overcome most of the CD IgA-mediated effects including the TG2 extracellular transamidase activity.Conclusions:Altogether our findings suggest that in endothelial cells CD IgA mediate the constitutive activation of extracellular TG2 by a mechanism involving the redox sensor protein TRX. © 2013 Nadalutti et al.

References Powered by Scopus

Identification of tissue transglutaminase as the autoantigen of celiac disease

1887Citations
N/AReaders
Get full text

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

1043Citations
N/AReaders
Get full text

Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease

578Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2

33Citations
N/AReaders
Get full text

Thioredoxin-1 selectively activates transglutaminase 2 in the extracellular matrix of the small intestine: Implications for celiac disease

32Citations
N/AReaders
Get full text

Ganoderma lucidum polysaccharide peptide attenuates skin flap ischemia-reperfusion injury in a thioredoxin-dependent manner

30Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Antonella Nadalutti, C., Korponay-Szabo, I. R., Kaukinen, K., Wang, Z., Griffin, M., Mäki, M., & Lindfors, K. (2013). Thioredoxin Is Involved in Endothelial Cell Extracellular Transglutaminase 2 Activation Mediated by Celiac Disease Patient IgA. PLoS ONE, 8(10). https://doi.org/10.1371/journal.pone.0077277

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 17

59%

Professor / Associate Prof. 8

28%

Researcher 4

14%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 11

44%

Agricultural and Biological Sciences 6

24%

Engineering 4

16%

Medicine and Dentistry 4

16%

Save time finding and organizing research with Mendeley

Sign up for free